Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application

Title:Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application

Volume: 10

Author(s): Xiaodan Jiao, Niloufar Ashtari, Maryam Rahimi-Balaei, Qi Min Chen, Ilnaz Badbezanchi, Shahla Shojaei, Adel Marzban, Nima Mirzaei, Seunghyuk Chung, Teng Guan, Jiasi Li, Jerry Vriend, Shahram Ejtemaei Mehr, Jiming Kong and Hassan Marzban*

Affiliation:

• Department of Human Anatomy and Cell Science, Rm129, BMSB, 745 Bannatyne Avenue, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, R3E 0J9,Canada

Keywords: Cholesterol, neurodegeneration, neurodevelopment, Rho GTPase, statins.

Abstract: The mevalonate cascade is a key metabolic pathway that regulates a variety of cellular functions and is thereby implicated in the pathophysiology of most brain diseases, including neurodevelopmental and neurodegenerative disorders. Emerging lines of evidence suggest that statins and Rho GTPase inhibitors are efficacious and have advantageous properties in treatment of different pathologic conditions that are relevant to the central nervous system. Beyond the original role of statins in lowering cholesterol synthesis, they have anti-inflammatory, antioxidant and modulatory effects on signaling pathways. Additionally, Rho GTPase inhibitors and statins share the mevalonate pathway as a common target of their therapeutic actions. In this review, we discuss potential mechanisms through which these drugs, via their role in the mevalonate pathway, exert their neuroprotective effects in neurodegenerative and neurodevelopmental disorders.

Cite this article as:

Jiao Xiaodan, Ashtari Niloufar, Rahimi-Balaei Maryam, Chen Min Qi, Badbezanchi Ilnaz, Shojaei Shahla, Marzban Adel, Mirzaei Nima, Chung Seunghyuk, Guan Teng, Li Jiasi, Vriend Jerry, Mehr Ejtemaei Shahram, Kong Jiming and Marzban Hassan*, Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application, Current Molecular Pharmacology 2017; 10 (2) . https://dx.doi.org/10.2174/1874467209666160112125446